Xconomy: naltrexone News, Articles and Opinions

“naltrexone” Archives

Entry	Author	Date	Location
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More	Frank Vinluan	12/13/19	National
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No	Ben Fidler	06/16/17	National
Alkermes Drug Approved for Opioid Addiction, Genzyme Faces Shareholder Lawsuits, NinePoint Gets $33M, & More Boston-Area Life Sciences News	Erin Kutz	10/15/10	Boston
Alkermes to Seek FDA Approval of Anti-Addiction Drug	Ryan McBride	11/16/09	Boston
Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Webinar
Sept. 15 – Challenges of Implementing Innovation in Drug Discovery & Development
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
Eurofins Discovery

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Sponsored · Special Report
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future
Hyperinflation in rents is over
Hughes Marino

Xconomy on Demand

We offer a number of ways to subscribe for free!